Skip to main content

Table 4 Detailed description of TCGA tumor datasets having a statistically significant APE1/NPM1 gene expression correlation. Every cohort is represented by its symbol (as shown in Additional file 6: Figure S5), full description, RNA-seq gene expression correlation between APE1 and NPM1 and statistical significance of the data

From: APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC

Cohort Description Corr P value
PRAD Prostate adenocarcinoma 0.644 1.58E-59
KICH Kidney Chromophobe 0.590 1.88E-07
PAAD Pancreatic adenocarcinoma 0.517 1.41E-13
SARC Sarcoma 0.503 5.22E-18
GBMLGG Glioma 0.501 9.73E-44
THYM Thymoma 0.462 1.07E-07
LUAD Lung adenocarcinoma 0.448 8.68E-27
THCA Thyroid carcinoma 0.445 1.00E-25
KIPAN Pan-kidney cohort (KICH+KIRC+KIRP) 0.431 1.30E-41
KIRP Kidney renal papillary cell carcinoma 0.431 1.48E-14
STES Stomach and Esophageal carcinoma 0.415 2.24E-26
STAD Stomach adenocarcinoma 0.412 1.77E-18
ESCA Esophageal carcinoma 0.398 2.28E-08
KIRC Kidney renal clear cell carcinoma 0.392 5.52E-21
CESC Cervical squamous cell carcinoma and endocervical adenocarcinoma 0.380 7.13E-12
UCEC Uterine Corpus Endometrial Carcinoma 0.369 4.73E-19
LIHC Liver hepatocellular carcinoma 0.348 5.09E-12
COAD Colon adenocarcinoma 0.344 3.87E-14
GBM Glioblastoma multiforme 0.306 1.17E-04
COADREAD Colorectal adenocarcinoma 0.291 1.25E-13
BRCA Breast invasive carcinoma 0.282 1.74E-21
SKCM Skin Cutaneous Melanoma 0.270 5.76E-03
HNSC Head and Neck squamous cell carcinoma 0.264 1.04E-09
LUSC Lung squamous cell carcinoma 0.246 2.31E-08
BLCA Bladder Urothelial Carcinoma 0.244 6.14E-07